Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT00649753 Completed - Pain Clinical Trials

Algometer and Category II Pelvic Blocking and Cranial Protocol

Algometer
Start date: March 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the relationship of pelvic blocking and protocol for cranial adjusting with specific pain areas as outlined by Dr. Bertrand DeJarnette in the Category II/sacroiliac protocol. An algometer will be used to determine the level of pain at specific points before and after each treatment of pelvic blocking with or without cranial adjusting.

NCT ID: NCT00647127 Completed - Pain Clinical Trials

Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain

Start date: February 2008
Phase: Phase 3
Study type: Interventional

To compare the analgesic and anti-hyperalgesic effect of Buprenorphine and Fentanyl against experimental pain in skin, muscle and bone. The study will be performed with healthy volunteers.

NCT ID: NCT00646945 Completed - Pain Clinical Trials

Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology

Start date: September 2007
Phase: Phase 4
Study type: Interventional

In the oncology practice, The National Union of the Centres of Fight Against the Cancer recently published the Standards, Options and Recommendations for the coverage of the pains provoked during the invasive gestures of a short duration realized at patients affected by cancer. These support the use of the Kalinox ® 170 bar as therapeutic alternative for the preparation of the painful procedures of a short duration such as spinal taps or osseous at the adult.The objective of this study thus is to clarify the appropriate efficiency and the tolerance of the equimolar mixture protoxide of nitrogen / oxygen during invasive procedures realized in adult oncology with regard to the analgesic reference methods and to the effect placebo leads by the accompaniment of the patient during the procedure.

NCT ID: NCT00644787 Completed - Pain Clinical Trials

A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain

Start date: December 2007
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of fentanyl 1-day application (JNS020QD) transdermal patch (patch containing a drug that is put on the skin so the drug can enter the body through the skin) and to assess the non-inferiority of fentanyl 1-day application transdermal patch to fentanyl 3-day application (JNS005) transdermal patch in participants with cancer pain.

NCT ID: NCT00643006 Completed - Pain Clinical Trials

Physical Exercise and Its Impact on Signs of Inflammation in Fibromyalgia

Start date: January 2008
Phase: N/A
Study type: Interventional

The study aims to compare low-intensive and high-intensive physical exercise and its impact on physical function, pain and signs of inflammation.

NCT ID: NCT00641667 Completed - Pain Clinical Trials

An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain

Start date: January 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of fentanyl one-day transdermal patch (patch containing a drug that is put on the skin so the drug will enter the body through the skin) in participants switched from morphine preparations, oral oxycodone preparations, fentanyl citrate injection or fentanyl patch for cancer pain.

NCT ID: NCT00641303 Completed - Breast Cancer Clinical Trials

Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer

Start date: May 2008
Phase: N/A
Study type: Interventional

RATIONALE: Acupuncture may help relieve muscle and bone pain caused by aromatase inhibitor therapy, such as letrozole, exemestane, and anastrozole. PURPOSE: This randomized phase II trial is studying acupuncture to see how well it works in reducing muscle and bone symptoms in women receiving letrozole, exemestane, or anastrozole for stage 0, stage I, stage II, or stage III breast cancer.

NCT ID: NCT00640042 Completed - Pain Clinical Trials

Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza

ACCESS 2008
Start date: March 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to provide information in a broad, "real world" population of chronic pain patients assessing both pain control with AVINZA as well as the potential risk for misuse and abuse.

NCT ID: NCT00638729 Completed - Pain Clinical Trials

Clonidine Versus Midazolam for Premedication

Start date: August 2005
Phase: N/A
Study type: Interventional

alpha2-agonists like clonidine offer several useful effects that make these drugs an interesting alternative to benzodiazepines for pharmacological premedication. We therefore sought to determine the effect of pre-anesthetic medication with clonidine vs. midazolam in a randomized, double-blind, placebo controlled study. Effects of pre-anesthetic medication were assessed on (1) bispectral index (BIS),(2) sedation score and visual analog scales for anxiety and pain, (3) neuropsychologic tests to assess cognitive function and (4) circulating stress hormones.

NCT ID: NCT00637975 Completed - Pain Clinical Trials

Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain

Start date: September 2007
Phase: Phase 2
Study type: Interventional

The aim of the study is to assess tolerability and activity of oxycodone and pregabalin in combination for the treatment of oncological neuropathic pain with two different strategies.